Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

  Refine by:

Refine by:

Format

3 records – page 1 of 1.

New horizons in the treatment of breast cancer : selected proceedings from the 28th annual San Antonio Breast Cancer Symposium, December 8-11, 2005

https://bccalibrary.andornot.com/en/permalink/catalog14811
[Toronto, ON]: Kaleidoscope Strategic , 2006.
Audience
Professional
Call Number
WP870 N532m 2006
Availability
1 copy, 1 available
Clinical symposia report : a Canadian perspective : feature review "Targeting optimal adjuvant therapy for Her2-positive breast cancer" (by Deanna McLeod and Zoe Agnidis)
More Information
Editor
Mackey, John R
McLeod, Deanna
Agnidis, Zoe
Place of Publication
[Toronto, ON]
Publisher
Kaleidoscope Strategic
Publication Date
2006
Subjects
Breast Neoplasms - drug therapy
Antineoplastic Agents
Antibodies, Monoclonal - therapeutic use
Abstract
Clinical symposia report : a Canadian perspective : feature review "Targeting optimal adjuvant therapy for Her2-positive breast cancer" (by Deanna McLeod and Zoe Agnidis)
Language
English
Material Type
Book
Audience
Professional
Location
Vancouver Library
Call Number
WP870 N532m 2006

Copies

c.1 BC Cancer Agency VAN Library Available
Show Less

Administering Rituxan (rituximab) : a practical guide

https://bccalibrary.andornot.com/en/permalink/catalog18131
Hewitt, Karen, Zanke, Brent, Berinstein, Neil. Mississauga, ON: Hoffmann-La Roche Limited , 2000.
Audience
Patient or Public
Call Number
QZ267 A238 2000
Availability
1 copy, 1 available
More Information
Author
Hewitt, Karen
Zanke, Brent
Berinstein, Neil
Place of Publication
Mississauga, ON
Publisher
Hoffmann-La Roche Limited
Publication Date
2000
Physical Description
colour ; 15 minutes
Subjects
Antibodies, Monoclonal - therapeutic use
Lymphoma, Non-Hodgkin - therapy
Antineoplastic Agents - administration & dosage
Language
English
Material Type
DVD
Video
Audience
Patient or Public
Location
Vancouver Library
Call Number
QZ267 A238 2000

Copies

c.1 BC Cancer Agency VAN Library Available
Show Less

RANK ligand : a key signal in cancer-induced bone disease and hormone ablative therapy-induced bone loss

https://bccalibrary.andornot.com/en/permalink/catalog19811
Amgen Inc. Thousand Oaks, Calif.: Amgen Inc. , 2009.
Audience
Professional
Call Number
WE258 R198 2009
Availability
1 copy, 1 available
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
More Information
Author
Amgen Inc.
Place of Publication
Thousand Oaks, Calif.
Publisher
Amgen Inc.
Publication Date
2009
Subjects
RANK Ligand - metabolism
Osteoblasts
Osteoclasts
Antibodies, Monoclonal - therapeutic use
Bone Neoplasms - secondary
Bone Resorption
Osteoporosis - therapy
Antineoplastic Agents, Hormonal - adverse effects
Abstract
Introduction
RANK ligand in bone biology
Bone metastases
Multiple myeloma
Skeletal-related events (SREs)
Hormone ablative therapy-induced bone loss
Language
English
Material Type
Video
DVD
Audience
Professional
Location
Abbotsford Library
Call Number
WE258 R198 2009

Copies

c.1 BC Cancer Agency ARHCC Library Available
Show Less